Il y a eu 50 transactions d'initiés récentes enregistrées pour Becton, Dickinson and Company (BDX), dont 28 achats et 15 ventes. Le total des achats d'initiés s'élève à RSU Award et le total des ventes d'initiés à $918.06K.
Les initiés notables ayant une activité récente comprennent Neal Shana Carol, Feld Michael, Minnix Lanesha. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.
Transactions d'Initiés — BDX
| Date |
Nom |
Rôle |
Type de Transaction |
Actions |
Prix Moyen |
Valeur |
Actions détenues |
| 2026-04-06 |
Neal Shana Carol |
EVP and Chief People Officer |
Retenue Fiscale RSU |
1,146 |
- |
- |
23,966 |
| 2026-03-26 |
Feld Michael |
EVP, Chief Revenue Officer |
Vente Informative |
75 |
$156.83 |
$11.76K |
21,233 |
| 2026-03-16 |
Minnix Lanesha |
EVP and General Counsel |
Inconnu |
- |
- |
- |
- |
| 2026-03-16 |
Minnix Lanesha |
EVP and General Counsel |
Attribution de RSU |
7,492 |
- |
- |
7,492 |
| 2026-03-02 |
Spikner Pamela L. |
SVP Controller & CAO |
Attribution de RSU |
931 |
- |
- |
3,323 |
| 2026-03-02 |
Roque Vitor |
Interim CFO |
Attribution de RSU |
931 |
- |
- |
6,510 |
| 2026-02-26 |
Feld Michael |
EVP, Chief Revenue Officer |
Vente Informative |
75 |
$181.84 |
$13.64K |
21,308 |
| 2026-02-18 |
Scott Bertram L |
Director |
Vente Informative |
953 |
$182.61 |
$174.03K |
36,763 |
| 2026-02-04 |
Jones Christopher Ian Montague |
Director |
Attribution de RSU |
272 |
- |
- |
11,649 |
| 2026-02-04 |
Huffines Robert Luther |
Director |
Attribution de RSU |
100 |
- |
- |
100 |
| 2026-02-04 |
Byington Carrie L |
Director |
Attribution de RSU |
30 |
- |
- |
1,714 |
| 2026-02-01 |
Urbini Massimiliano |
EVP & Chief Isc Officer |
Inconnu |
- |
- |
- |
4,133 |
| 2026-01-27 |
Ring Timothy M |
Director |
Attribution de RSU |
1,098 |
- |
- |
59,160 |
| 2026-01-27 |
Eckert R Andrew |
Director |
Attribution de RSU |
1,098 |
- |
- |
10,423 |
| 2026-01-27 |
Scott Bertram L |
Director |
Attribution de RSU |
1,098 |
- |
- |
37,716 |
| 2026-01-27 |
Hayes Gregory |
Director |
Attribution de RSU |
1,098 |
- |
- |
7,159 |
| 2026-01-27 |
Jones Christopher Ian Montague |
Director |
Attribution de RSU |
1,098 |
- |
- |
24,304 |
| 2026-01-27 |
Henderson Jeffrey William |
Director |
Attribution de RSU |
1,098 |
- |
- |
9,143 |
| 2026-01-27 |
Brown William M |
Director |
Attribution de RSU |
1,098 |
- |
- |
4,663 |
| 2026-01-27 |
Huffines Robert Luther |
Director |
Attribution de RSU |
1,098 |
- |
- |
1,279 |
| 2026-01-27 |
Wright Jacqueline |
Director |
Attribution de RSU |
1,098 |
- |
- |
1,279 |
| 2026-01-27 |
Byington Carrie L |
Director |
Attribution de RSU |
1,098 |
- |
- |
5,018 |
| 2026-01-27 |
Waldstreicher Joanne |
Director |
Attribution de RSU |
1,098 |
- |
- |
3,391 |
| 2026-01-26 |
Feld Michael |
EVP, Cro & Pres. Life Sciences |
Vente Informative |
75 |
$202.73 |
$15.2K |
16,431 |
| 2026-01-21 |
Spikner Pamela L. |
SVP Controller & CAO |
Retenue Fiscale RSU |
84 |
- |
- |
1,832 |
| 2026-01-15 |
Garrison Michael David |
EVP & Pres Med.essntl&biopharm |
Exercice d'Options (Vente) |
3,054 |
$167.91 |
$512.8K |
- |
| 2026-01-03 |
Shan David |
EVP and Chief Isc Officer |
Retenue Fiscale RSU |
44 |
- |
- |
8,926 |
| 2025-12-26 |
Feld Michael |
EVP, Cro & Pres. Life Sciences |
Vente Informative |
74 |
$196.08 |
$14.51K |
16,506 |
| 2025-12-17 |
Garrison Michael David |
EVP & Pres Med.essntl&biopharm |
Vente Informative |
629 |
$196.03 |
$123.3K |
13,105 |
| 2025-12-05 |
Roque Vitor |
Interim CFO |
Inconnu |
- |
- |
- |
4,477 |
| 2025-12-01 |
Huffines Robert Luther |
Director |
Inconnu |
- |
- |
- |
- |
| 2025-12-01 |
Huffines Robert Luther |
Director |
Attribution de RSU |
180 |
- |
- |
180 |
| 2025-12-01 |
Wright Jacqueline |
Director |
Inconnu |
- |
- |
- |
- |
| 2025-12-01 |
Wright Jacqueline |
Director |
Attribution de RSU |
180 |
- |
- |
180 |
| 2025-12-01 |
Feld Michael |
EVP, Cro & Pres. Life Sciences |
Vente Informative |
75 |
$193.36 |
$14.5K |
16,580 |
| 2025-11-26 |
Urbini Massimiliano |
EVP & Chief Isc Officer |
Inconnu |
1,984 |
$224.25 |
$444.91K |
- |
| 2025-11-26 |
Polen Thomas E Jr |
Chairman, CEO and President |
Retenue Fiscale RSU |
17,421 |
- |
- |
105,471 |
| 2025-11-26 |
Goette Roland |
EVP and President, Emea |
Attribution de RSU |
1,906 |
- |
- |
16,123 |
| 2025-11-26 |
Muhsin Bilal |
EVP & President Connected Care |
Attribution de RSU |
9,530 |
- |
- |
21,751 |
| 2025-11-26 |
Neal Shana Carol |
EVP and Chief People Officer |
Attribution de RSU |
6,727 |
- |
- |
20,255 |
| 2025-11-26 |
Delorefice Christopher |
EVP & Chief Financial Officer |
Retenue Fiscale RSU |
4,245 |
- |
- |
22,982 |
| 2025-11-26 |
Mocherla Pavan Kumar |
EVP & President, Greater Asia |
Attribution de RSU |
2,208 |
- |
- |
5,055 |
| 2025-11-26 |
Garrison Michael David |
EVP & Pres Med.essntl&biopharm |
Attribution de RSU |
7,568 |
- |
- |
12,455 |
| 2025-11-26 |
Byrd Richard |
EVP & President Interventional |
Attribution de RSU |
6,447 |
- |
- |
13,183 |
| 2025-11-26 |
Shan David |
EVP and Chief Isc Officer |
Attribution de RSU |
3,504 |
- |
- |
8,079 |
| 2025-11-26 |
Spikner Pamela L. |
Svpcontroller & Chief Acct Off |
Attribution de RSU |
1,234 |
- |
- |
1,916 |
| 2025-11-26 |
Feld Michael |
EVP, Cro & Pres. Life Sciences |
Retenue Fiscale RSU |
419 |
- |
- |
16,655 |
| 2025-11-26 |
Roque Vitor |
Interim CFO |
Inconnu |
1,849 |
$224.25 |
$414.64K |
- |
| 2025-11-07 |
Scott Bertram L |
Director |
Vente Informative |
217 |
$176.58 |
$38.32K |
35,816 |
| 2025-11-04 |
Jones Christopher Ian Montague |
Director |
Attribution de RSU |
168 |
- |
- |
11,316 |
■ Informatif — transaction sur marché ouvert (la plus significative)
■ Non informatif (achat) — récompense, exercice d'option, conversion
■ Non informatif (vente) — retenue fiscale, vente à l'acquisition
■ Neutre — don, fiducie, expiration
Les autres consultent aussi
